New dual-immunotherapy combo tested in advanced cancers
NCT ID NCT05858736
First seen Apr 10, 2026 · Last updated May 07, 2026 · Updated 5 times
Summary
This early-phase study tests a new drug, AI-061, which combines two immunotherapy agents (anti-PD-1 and anti-CTLA-4) into one treatment for people with advanced solid tumors that have stopped responding to standard therapies. The main goal is to find the safest dose and check for side effects. About 18 adults with various cancers like melanoma, lung, or ovarian cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Research SA
Adelaide, South Australia, 5000, Australia
-
Mater Misericordiae Ltd.
Brisbane, Queensland, 4006, Australia
-
Southern Oncology Clinical Research Unit
Bedford Park, South Australia, 5042, Australia
-
St. Vincent's Private Hospital
Darlinghurst, New South Wales, 2010, Australia
-
Tasman Oncology Research
Southport, Queensland, 4120, Australia
Conditions
Explore the condition pages connected to this study.